Clinical Trials Browser

INDUSTRY × Voriconazole × Clear all

NCT04865419 2025-06-15

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Phase 1 Terminated

46 enrolled 12 charts

Haematological Malignancies

NCT02014558 2024-12-03

Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1/2 Completed

265 enrolled 80 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04551963 2024-10-26

Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies

Phase 1 Completed

26 enrolled 20 charts

B-cell Malignancies

NCT01686607 2024-10-21

MYCOS

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT02381080 2017-06-26

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01480219 2013-03-11

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

467 enrolled 6 charts

Non-Melanoma Skin Carcinoma

NCT00143312 2009-10-06

VOSIFI

Phase 4 Completed

45 enrolled 15 charts

Other hematologic neoplasm

Invasive Fungal Infections, Leukemia